Jones Michael L
SEC CIK 1800060 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BCRX | BIOCRYST PHARMACEUTICALS INC | Exec. Dir, Fin - PAO | 16.7K | — | $156.3K | 7 | 2021-12-14 | 2022-12-19 |
Most active insiders at BCRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barnes Alane P | CLO | — | $3.46M |
| 2 | HEGGIE THERESA | Dir | — | $504.8K |
| 3 | McKee Amy E | Dir | — | $100.3K |
| 4 | SANDERS MACHELLE | Dir | — | $68.5K |
| 5 | Menon Sandeep | Chief R, D Off | — | — |
| 6 | Ghias Babar | CFO | — | — |
| 7 | Gayer Charles K | Pres, CCO | — | — |
| 8 | Milne Jill C. | Dir | — | — |
| 9 | Frank Steven | Dir | — | — |
| 10 | Galson Steven K | Dir | — | — |
Jones Michael L made no open-market trades at BCRX in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-21 | 2022-12-19 | BCRX | BIOCRYST PHARMACEUTICALS INC | Jones Michael L | Exec. Dir, Fin - PAO | A - Grant | $0.00 | +5,900 | 16.7K | +55% | $0 |
| 2022-12-19 | 2022-12-15 | BCRX | BIOCRYST PHARMACEUTICALS INC | Jones Michael L | Exec. Dir, Fin - PAO | S - Sale | $10.90 | -445 | 10.8K | -4% | -$4,850 | |
| D | 2022-12-02 | 2022-12-01 | BCRX | BIOCRYST PHARMACEUTICALS INC | Jones Michael L | Exec. Dir, Fin - PAO | S - Sale+OE | $13.01 | -8,600 | 11.2K | -43% | -$111.9K |
| D | 2022-12-02 | 2022-12-01 | BCRX | BIOCRYST PHARMACEUTICALS INC | Jones Michael L | Exec. Dir, Fin - PAO | M - OptEx | $1.42 | +8,600 | 19.8K | +77% | +$12.2K |
| D | 2022-03-03 | 2022-03-01 | BCRX | BIOCRYST PHARMACEUTICALS INC | Jones Michael L | Exec. Dir, Fin - PAO | S - Sale+OE | $17.20 | -2,300 | 11.2K | -17% | -$39.6K |
| D | 2022-03-03 | 2022-03-01 | BCRX | BIOCRYST PHARMACEUTICALS INC | Jones Michael L | Exec. Dir, Fin - PAO | M - OptEx | $4.73 | +2,300 | 13.5K | +21% | +$10.9K |
| D | 2021-12-16 | 2021-12-14 | BCRX | BIOCRYST PHARMACEUTICALS INC | Jones Michael L | Exec. Dir, Fin - PAO | A - Grant | $0.00 | +5,850 | 11.2K | +109% | $0 |
Purchase Sale Sale after option exercise All abbreviations